The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

CHENG-MING PENG2026-10-162026-10-162022-09-01Pure ID: 15220675Pure UUID: ab76f2d4-9f94-43ec-a302-5797f0b8f6f410.1097/MPA.0000000000002125https://www.scopus.com/pages/publications/85145955248https://scholars.csmu.edu.tw/handle/123456789/26847enThe Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaA Single-Center Real-World Studyjournal article